PL3092217T3 - Nowy sposób wytwarzania indakaterolu lub jego farmaceutycznie dopuszczalnych soli - Google Patents
Nowy sposób wytwarzania indakaterolu lub jego farmaceutycznie dopuszczalnych soliInfo
- Publication number
- PL3092217T3 PL3092217T3 PL14877661T PL14877661T PL3092217T3 PL 3092217 T3 PL3092217 T3 PL 3092217T3 PL 14877661 T PL14877661 T PL 14877661T PL 14877661 T PL14877661 T PL 14877661T PL 3092217 T3 PL3092217 T3 PL 3092217T3
- Authority
- PL
- Poland
- Prior art keywords
- indacaterol
- preparation
- pharmaceutically acceptable
- acceptable salts
- novel process
- Prior art date
Links
- QZZUEBNBZAPZLX-QFIPXVFZSA-N indacaterol Chemical compound N1C(=O)C=CC2=C1C(O)=CC=C2[C@@H](O)CNC1CC(C=C(C(=C2)CC)CC)=C2C1 QZZUEBNBZAPZLX-QFIPXVFZSA-N 0.000 title 1
- 229960004078 indacaterol Drugs 0.000 title 1
- 150000003839 salts Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/24—Oxygen atoms attached in position 8
- C07D215/26—Alcohols; Ethers thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
- C07F7/1804—Compounds having Si-O-C linkages
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN116CH2014 | 2014-01-09 | ||
| EP14877661.0A EP3092217B1 (en) | 2014-01-09 | 2014-12-27 | A novel process for preparation of indacaterol or its pharmaceutically acceptable salts |
| PCT/IN2014/050006 WO2015104718A2 (en) | 2014-01-09 | 2014-12-27 | A novel process for preparation of indacaterol or its pharmaceutically acceptable salts |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3092217T3 true PL3092217T3 (pl) | 2020-11-16 |
Family
ID=53524447
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL14877661T PL3092217T3 (pl) | 2014-01-09 | 2014-12-27 | Nowy sposób wytwarzania indakaterolu lub jego farmaceutycznie dopuszczalnych soli |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US9682935B2 (pl) |
| EP (1) | EP3092217B1 (pl) |
| ES (1) | ES2815123T3 (pl) |
| PL (1) | PL3092217T3 (pl) |
| PT (1) | PT3092217T (pl) |
| WO (1) | WO2015104718A2 (pl) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108250140B (zh) * | 2016-12-28 | 2021-06-25 | 正大天晴药业集团股份有限公司 | 一种马来酸茚达特罗的制备方法 |
| CN108264483A (zh) * | 2016-12-31 | 2018-07-10 | 天津金耀集团有限公司 | 一种马来酸茚达特罗的制备方法 |
| WO2020202130A2 (en) * | 2019-04-04 | 2020-10-08 | Neuland Laboratories Limited | Improved process for the preparation of indacaterol maleate |
| EP4221707A4 (en) | 2020-09-29 | 2024-08-28 | Aerorx Therapeutics LLC | Liquid formulations of indacaterol |
| CA3255212A1 (en) * | 2022-03-30 | 2023-10-05 | Aerorx Therapeutics, Inc. | LIQUID FORMULATIONS OF INDACATEROL AND GLYCOPYRRONIUM |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9913083D0 (en) | 1999-06-04 | 1999-08-04 | Novartis Ag | Organic compounds |
| US6653323B2 (en) | 2001-11-13 | 2003-11-25 | Theravance, Inc. | Aryl aniline β2 adrenergic receptor agonists |
| TWI324150B (en) | 2003-02-28 | 2010-05-01 | Novartis Ag | Process for preparing 5-[(r)-2-(5,6-diethyl-indan-2-ylamino)-1-hydroxy-ethyl]-8-hydroxy-(1h)-quinolin-2-one salt |
| TWI324151B (en) | 2003-04-02 | 2010-05-01 | Novartis Ag | Process for the preparation of 5-(haloacetyl)-8-substituted oxy-(1h)-quinolin-2-ones |
| GB0413960D0 (en) | 2004-06-22 | 2004-07-28 | Novartis Ag | Organic compounds |
| EP1953143A1 (en) | 2007-01-30 | 2008-08-06 | CHIESI FARMACEUTICI S.p.A. | Process for the preparation of 8-hydroxy-5-[(1R)-1-hydroxy-2[[(1R)-2-(4-methoxyphenyl)-1-methylethyl]amino]ethyl]-2(1H)-quinolinone monohydrochloride |
| WO2013132514A2 (en) | 2012-03-09 | 2013-09-12 | Rao Davuluri Ramamohan | A novel process for the preparation of (r)-5-[2-[(5, 6-diethyl-2, 3-dihydro-1h-inden-2-yl) amino]-1-hydroxyethyl]-8-hydroxy quinolin-2(1h)-one |
| WO2014044288A1 (en) | 2012-09-21 | 2014-03-27 | Crystal Pharma Sa | Methods for the preparation of indacaterol and pharmaceutically acceptable salts thereof |
| EP2978745B1 (en) | 2013-03-27 | 2017-03-15 | Laboratorios Lesvi, S.L. | Process for the manufacture of (r)-5-[2-(5,6-diethylindan-2-ylamino)-1-hydroxyethyl]-8-hydroxy-(1h)-quinolin-2-one |
-
2014
- 2014-12-27 PL PL14877661T patent/PL3092217T3/pl unknown
- 2014-12-27 US US15/110,410 patent/US9682935B2/en active Active
- 2014-12-27 EP EP14877661.0A patent/EP3092217B1/en not_active Revoked
- 2014-12-27 ES ES14877661T patent/ES2815123T3/es active Active
- 2014-12-27 PT PT148776610T patent/PT3092217T/pt unknown
- 2014-12-27 WO PCT/IN2014/050006 patent/WO2015104718A2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| EP3092217A4 (en) | 2017-05-03 |
| ES2815123T3 (es) | 2021-03-29 |
| WO2015104718A2 (en) | 2015-07-16 |
| EP3092217B1 (en) | 2020-06-03 |
| US9682935B2 (en) | 2017-06-20 |
| WO2015104718A3 (en) | 2016-03-03 |
| PT3092217T (pt) | 2020-09-04 |
| US20160326118A1 (en) | 2016-11-10 |
| EP3092217A2 (en) | 2016-11-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA201704877B (en) | Process for the preparation of a diarylthiohydantoin compound | |
| SG11201704014WA (en) | Process for preparing a polyetheramine | |
| GB201403356D0 (en) | A process for preparing a nicotine-containing formulation | |
| IL281292A (en) | Processes for preparing a diarylthiohydantoin compound | |
| PL3295941T3 (pl) | Sposób wytwarzania postaci a grapiprantu | |
| IL254530A0 (en) | Preparation method of crystalline form a of pci-32765 | |
| IL237886A0 (en) | Capsule for making a drink | |
| PL3046590T3 (pl) | Sposób wytwarzania ciekłego preparatu farmaceutycznego | |
| PT3092217T (pt) | Processo inovador para preparação de indacaterol ou dos seus sais farmaceuticamente aceitáveis | |
| IL243795A0 (en) | A process for the preparation of a quinazoline derivative | |
| ZA201607265B (en) | A process for preparation of levothyroxine and salts thereof | |
| EP3174878A4 (en) | A process for the preparation of palbociclib | |
| PL3223799T3 (pl) | Sposób otrzymywania kompozycji składnik farmaceutyczny-polimer | |
| LT3393246T (lt) | Chelanto gamybos būdas | |
| HUP1500034A1 (en) | Process for the preparation of vortioxetine salts |